Actively Recruiting

Age: 18Years - 99Years
All Genders
NCT06792994

A Prospective Observational Trial to Assess Treatment Sequences and Factors That Impact Overall Sur-vival in Patients With Chronic Lymphocytic Leukaemia (CLL) Treated Within First-line Studies of the GCLLSG

Led by German CLL Study Group · Updated on 2026-04-30

2000

Participants Needed

2

Research Sites

226 weeks

Total Duration

On this page

Sponsors

G

German CLL Study Group

Lead Sponsor

G

GELLC (Grupo Español de Leucemia Linfocítica Crónica)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This observational trial is designed to investigate long-term survival with regard to the primary endpoint overall survival (OS) after start of first-line treatment.

CONDITIONS

Official Title

A Prospective Observational Trial to Assess Treatment Sequences and Factors That Impact Overall Sur-vival in Patients With Chronic Lymphocytic Leukaemia (CLL) Treated Within First-line Studies of the GCLLSG

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Voluntarily signed and dated informed consent approved by an ethics committee or institutional review board
  • Documented diagnosis of chronic lymphocytic leukemia (CLL) at inclusion in a first-line GCLLSG study
  • Received first-line treatment within the CLL13, CLL14, or CLL17 GCLLSG studies
  • Subsequent therapy lines documented either during first-line study or within this observational trial
  • Willing and able to comply with study procedures
Not Eligible

You will not qualify if you...

  • No participation in CLL13, CLL14, or CLL17 first-line GCLLSG studies
  • Legal incapacity
  • Institutionalization by regulatory or court order
  • Dependence on the sponsor or investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

University Hospital Cologne

Cologne, Germany, 50924

Actively Recruiting

2

Universitätsklinikum Ulm

Ulm, Germany, 89081

Actively Recruiting

Loading map...

Research Team

K

Kirsten Fischer, MD

CONTACT

A

Aline Zey, Dipl.Biol.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here